x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization. Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist

science life sciences

All Episodes

41:37

The passionate problem solver

Molecule to Market: Inside the outsourcing space ·

2021/02/15

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Robert Lee Ph.D., President at the CDMO Division of Lubrizol Life Science Health (LLS). Rob has over 30 years’ experience in the pharmaceutical R&D space and his areas of expertise include drug delivery, formulation development, analytical sciences and sterile manufacturing. With a Ph.D. in Physical Bioorganic Chemistry, Rob has published more than three dozen articles and five

en

39:10

The entrepreneurial scientist

Molecule to Market: Inside the outsourcing space ·

2021/02/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alok Tayi, Vice President of Life Sciences at Egnyte and the founder of the Biotech 2050 podcast. Alok has a very impressive academic and entrepreneurial background in life sciences, before running the fast-growing life science division at Egnyte, he was a Co-Founder of PreScouter and TetraScience, raising millions along the way. Having completed a postdoctoral fellowship at

en

48:43

The sales guru

Molecule to Market: Inside the outsourcing space ·

2021/01/28

In this episode of Molecule to Market, we do things a little differently with an experimental episode. You’ll go inside the outsourcing space of the global drug development sector with the best-selling sales author, Ian Altman. Ian started, sold, and grew his prior companies from zero to over one billion dollars in value. He’s a co-author of the bestseller, Same Side Selling, now in its second edition. He is the author of hundreds of articles on Forbes and Inc. Ian is recognized as one of the

en

52:02

Marathons. Wine. And 30 years in healthcare.

Molecule to Market: Inside the outsourcing space ·

2021/01/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Marco Chiado’ Piat, President, at Terumo Pharmaceutical Solutions part of Terumo. Marco has worked in the pharma and healthcare sector since the early 1990s. His impressive experience has included eight years at McKinsey before he founded a VC business. He then had several senior roles at medical device specialist LivaNova before joining Terumo Pharmaceutical Solutions in 2017,

en

51:55

The industry guru

Molecule to Market: Inside the outsourcing space ·

2021/01/14

In this one hour special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jim Miller. If you’ve worked in the bio and pharmaceutical CDMO space for a few years, then there’s a very good chance you will know my guest today. Jim is a renowned expert in the space and a regular speaker at all the major trade conferences including CPhI WW. He made his name in the sector after founding and growing PharmSource with his wife Judy, an online

en

21:20

10 Trends for 2021

Molecule to Market: Inside the outsourcing space ·

2021/01/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with... Raman Sehgal, founder of ramarketing and the Molecule to Market podcast. Your host, Raman shares ten trends that he expects to see in 2021 and beyond based on themes from podcast interviews and expert insights gathered in 2020. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing

en

51:46

The CDMO Disrupter

Molecule to Market: Inside the outsourcing space ·

2020/12/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tia Lyles-Williams, CEO of LucasPye Bio. Tia is the first African-American Queer Woman to own & lead a Biopharma Large-Scale Manufacturing Company in the US. She has spent 20 years in the industry formerly working for the U.S. Federal Government, Big Pharma and Small Biotech Companies, before setting up her own CDMO. Tia is not only highly knowledgeable about the biotechnology

en

48:56

The biologic CDMO growth guy

Molecule to Market: Inside the outsourcing space ·

2020/11/24

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Roger Lias, Chief Executive Officer at Stelis Biopharma. A fellow-Brit, Roger is a graduate of the University of Southampton. He also holds a PhD in Biotechnology from the University of Cambridge. His experience of the biopharma CDMO space in particular spans over 30 years including roles with the likes of Lonza, Diosynth, KBI Biopharma, Cytovance Biologics, Eden Biodesign,

en

41:04

Leading M&A at a top-5 global CDMO

Molecule to Market: Inside the outsourcing space ·

2020/11/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mark Quick, Executive Vice President, Corporate Development at Recipharm. In the decade that Mark and Raman have known each other, Mark has risen from a BD role in a small Swedish CMO, to becoming one of the key leaders in a business that has transitioned into becoming one of the top global CDMOs, where Mark has spearheaded the M&A deals. A graduate in Industrial Studies, Mark

en

48:27

The virotherapy virtuoso

Molecule to Market: Inside the outsourcing space ·

2020/11/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Stefan Beyer, President and Managing Director at Vibalogics and Tom Hochuli, Chief Executive Officer at Vibalogics. Who is this dynamic duo you ask? Stefan has spent the bulk of his career in the vaccines and biologics space. He has been head of Vibalogics for almost 13 years, steering the company from a local startup, to global CDMO and world leader in the production of

en

01:08:51

Roundtable: Collaboration and driving efficiency

Molecule to Market: Inside the outsourcing space ·

2020/10/16

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Dexter Tjoa, Chief Executive Officer at Tjoapack, Erik Haeffler, VP Manufacturing Services & Head of Sustainability at Recipharm AB, John Ross, President at Mayne Pharma and Metrics Contract Services, and Mark Emalfarb, CEO, Board Member and Founder at Dyadic

en

01:03:35

Roundtable: Latest trends in CDMO

Molecule to Market: Inside the outsourcing space ·

2020/10/15

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Roger Lias Chief Executive Officer at Stelis Biopharma Pvt. Ltd. and Stelis Biopharma LLC, Mark Quick, Executive Vice President Corporate Development at Recipharm AB, Lynn Allen, Vice President Of Business Development at MedPharm Ltd, Alfredo Gomez, Head of Site

en

53:22

Roundtable: Clinical trials in 2020 and beyond

Molecule to Market: Inside the outsourcing space ·

2020/10/15

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Torkel Gren, Senior Director, Technology Officer & Strategic Investments at Recipharm, Sascha Sonnenberg, Global Head of Business Development at Sharp Clinical Services, Vincent Dunne, CEO at Wasdell Group and Stephen Rode, Business Development Manager for Lonza

en

01:02:01

Roundtable: Global geography and the pharma and bio...

Molecule to Market: Inside the outsourcing space ·

2020/10/13

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Erik Haeffler, VP Manufacturing Services & Head of Sustainability at Recipharm AB, Dan Stanton, Founder and Editor of Bioprocess Insider and Stefano Console, Senior Advisor and Founder at Oriento. Join us as we discuss the impact of COVID-19 on the pharma and bio

en

43:29

Scientist & champion powerlifter

Molecule to Market: Inside the outsourcing space ·

2020/09/29

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Shane Needham, Chief Founding Scientist, Director of the Board and Owner at Alturas Analytics, Inc. With a PHD in chemistry, Dr. Needham has spent almost 30 years in the sector. He started his career at Pfizer and went on to found his own company, Alturas Analytics, which focuses on solving complex bioanalytical problems. He has over 100 publications and external presentations in

en

46:25

From fax to SaaS: digitising the the pharma supply chain

Molecule to Market: Inside the outsourcing space ·

2020/09/22

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason Lacombe, CEO at Veratrak. A graduate of Toronto and Oxford University, Jason was recently named as one of Forbes 30 Under 30 and has also advised the WHO and EU. Today, his business is one of the fastest growing tech companies in the life science space. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jason, covering the impact

en

49:35

Successful outsourcing partnerships: now and then

Molecule to Market: Inside the outsourcing space ·

2020/09/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mary Christian, Senior Vice President, Regulatory at Lyndra Therapeutics. To say Mary has an impressive track record is an understatement. Across the last three decades she has worked for some of the biggest pharmaceutical companies in the world including Janssen and Bristol Myers Squibb before moving onto several fast growing biotech companies including Ironwood, Cyclerion and

en

40:55

Old world solutions won’t work for new world problems

Molecule to Market: Inside the outsourcing space ·

2020/08/31

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sara Lesina, Global Marketing Director of Pharma & Nutrition, Capsules and Health Ingredients at Lonza. A multilingual, international marketing leader, Sara oversees the global marketing and product line management team for the capsule business of Lonza, Capsugel®. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guest Sara Lesina, covering

en

38:28

Looking towards the future: A continuous mindset

Molecule to Market: Inside the outsourcing space ·

2020/08/25

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Carl-Åke Carlsson CEO at Xellia Pharmaceuticals. Like celebrated “one-club” football stars like Leo Messi at Barcelona, Alessandro Del Piero at Juventus and Steven Gerrard at Liverpool… Carl-Åke has been with Xellia since 1988. A pharmaceutical leader known for his class and commercial acumen, Carl‑Åke started in a finance position. He was soon diversifying into other areas and

en

32:31

Life in a boutique, specialist CDMO

Molecule to Market: Inside the outsourcing space ·

2020/08/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Manuel Leal, Business Development Director at IDIFARMA. A student of law and business, Manuel has carved a very impressive career in the outsourcing space all despite having no formal pharma and science background! He has spent the last decade helping take a little known, local formulation development firm in Northern Spain into a global, specialist CDMO. Your host, Raman

en

256 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter